The cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7221 cells.

To study the cytotoxicity of four alkaloids: brucine, strychnine, brucine N-oxide and isostrychnine from nux vomica on SMMC 7721 cells and their possible mechanisms, MET assay was used to examine the growth inhibitory effects of these alkaloids. Brucine revealed the strongest growth inhibitory effect on SMMC-7721 cells. Furthermore, as directly observed under an inverted microscope, fluorescent microscope and transmission electronic microscope, brucine caused SMMC-7721 cell shrinkage, membrane blobbing, formation of apoptotic body as well as nucleus condensation, all of which are typical characteristics of apoptotic programmed cell death. In addition, brucine dose-dependently caused SMMC-7721 cells apoptosis via formation of subdipolid DNA and phosphatidylserine externalization, as evidenced by flow cytometry analysis. The brucine-induced apoptosis was partially attributed to the activation of caspase 3 as well as cyclooxygenase 2 inhibition, since neither caspase 3 specific inhibitor, z-DEVD-fmk nor was exogenous addition of prostaglandin E(2) able to completely abrogate the brucine-induced SMMC 7721 cell apoptosis. In sum, this paper indicate that the major alkaloids present in the seed of Strychnos nux-vomica are effective against SMMC-7721 cells proliferation, among which brucine proceeds SMMC-7721 cells death via apoptosis, probably through the participation of caspase 3 and cyclooxygenase 2.

[1]  G. Selivanova.  p53: fighting cancer. , 2004, Current cancer drug targets.

[2]  Yu-lian Wu,et al.  Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[3]  M. Takemura,et al.  Non‐steroidal anti‐inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase‐2 protein expression in endometrial cancer cells , 2004, Cancer science.

[4]  F. Shen,et al.  Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China. , 2003, World journal of gastroenterology.

[5]  Yang Pan,et al.  [Pharmacokinetics of the alkaloids from the processed seeds of Strychnos nux-vomica in rats]. , 2003, Yao xue xue bao = Acta pharmaceutica Sinica.

[6]  M. Hattori,et al.  Cytotoxicities of alkaloids from processed and unprocessed seeds of Strychnos nux-vomica. , 1998, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[7]  R. Pérez-Tomás,et al.  Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosin. , 2002, Biochemical pharmacology.

[8]  B. Cai,et al.  Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. , 2003, Journal of ethnopharmacology.

[9]  L. Smets.  Programmed cell death (apoptosis) and response to anti-cancer drugs. , 1994, Anti-cancer drugs.

[10]  R. DuBois,et al.  COX-2: a molecular target for colorectal cancer prevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  T. Kawaguchi,et al.  Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation , 1999, Hepatology.

[12]  N. Bisset,et al.  The tertiary alkaloids of some Asian species of Strychnos , 1971, The Journal of pharmacy and pharmacology.

[13]  K. Takeyasu,et al.  Stimulation of Na,K-ATPase by Low Potassium Is Dependent on Transferrin , 2003, The Journal of Membrane Biology.

[14]  D. Fisher.  Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[15]  Sudhir Gupta.  Molecular mechanisms of apoptosis in the cells of the immune system in human aging , 2005, Immunological reviews.

[16]  Xiao-Hong Li,et al.  Nimesulide inhibits tumor growth in mice implanted hepatoma: overexpression of Bax over Bcl-2. , 2003, Acta pharmacologica Sinica.

[17]  M. Hsiao,et al.  Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase‐2 (COX‐2) expression and inhibited by a COX‐2–selective inhibitor, etodolac , 2001 .

[18]  G. Zauli,et al.  PI‐3K/Akt and NF‐κB/IκBα pathways are activated in Jurkat T cells in response to TRAIL treatment , 2005 .

[19]  J. Morrow,et al.  Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.

[20]  A. Watson.  manipulation of cell death — the development of novel strategies for the treatment of gastrointestinal disease , 1995, Alimentary pharmacology & therapeutics.

[21]  M. Hattori,et al.  Processing of nux vomica. II. Changes in alkaloid composition of the seeds of Strychnos nux-vomica on traditional drug-processing. , 1990, Chemical & pharmaceutical bulletin.